Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial
Lindsay N. Helget, Anne Davis‐Karim, James R. O’Dell, Ted R. Mikuls, Jeff A. Newcomb, Maria Androsenko, Mary T. Brophy, Bryant R. England, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Hongsheng Wu, Paul M. Palevsky
Topics & Concepts
FebuxostatMedicineGoutAllopurinolSubgroup analysisInternal medicineHyperuricemiaIntensive care medicineUric acidMeta-analysisGout, Hyperuricemia, Uric AcidKidney Stones and Urolithiasis TreatmentsAcute Kidney Injury Research